In conclusion, in the combined CB and AKK treatment group, low-abundance Lactobacilli significantly increased the levels of anti-inflammatory factors IL-4 and IL-10, and high-abundance Bifidobacteria reduced the level of pro-inflammatory factor IL-6, resulting in a significant improvement in colonic inflammation in IBD mice. The gene discussed is IL10; the disease is inflammatory bowel disease.